These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

327 related articles for article (PubMed ID: 29235145)

  • 1. Macrolide and fluoroquinolone resistance in Mycoplasma genitalium in two Swedish counties, 2011-2015.
    Hadad R; Golparian D; Lagos AC; Ljungberg J; Nilsson P; Jensen JS; Fredlund H; Unemo M
    APMIS; 2018 Feb; 126(2):123-127. PubMed ID: 29235145
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence of macrolide and fluoroquinolone resistance-mediating mutations in Mycoplasma genitalium in five cities in Russia and Estonia.
    Shipitsyna E; Rumyantseva T; Golparian D; Khayrullina G; Lagos AC; Edelstein I; Joers K; Jensen JS; Savicheva A; Rudneva N; Sukhanova L; Kozlov R; Guschin A; Unemo M
    PLoS One; 2017; 12(4):e0175763. PubMed ID: 28407014
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Remarkable increase in fluoroquinolone-resistant Mycoplasma genitalium in Japan.
    Kikuchi M; Ito S; Yasuda M; Tsuchiya T; Hatazaki K; Takanashi M; Ezaki T; Deguchi T
    J Antimicrob Chemother; 2014 Sep; 69(9):2376-82. PubMed ID: 24894419
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Macrolide and fluoroquinolone associated mutations in Mycoplasma genitalium in a retrospective study of male and female patients seeking care at a STI Clinic in Guangzhou, China, 2016-2018.
    Ke W; Li D; Tso LS; Wei R; Lan Y; Chen Z; Zhang X; Wang L; Liang C; Liao Y; Chen H; Liu Y; Zheng H; Yang L
    BMC Infect Dis; 2020 Dec; 20(1):950. PubMed ID: 33308173
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Failure of moxifloxacin treatment in Mycoplasma genitalium infections due to macrolide and fluoroquinolone resistance.
    Couldwell DL; Tagg KA; Jeoffreys NJ; Gilbert GL
    Int J STD AIDS; 2013 Oct; 24(10):822-8. PubMed ID: 24052013
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fluoroquinolone and macrolide resistance-associated mutations in Mycoplasma genitalium.
    Tagg KA; Jeoffreys NJ; Couldwell DL; Donald JA; Gilbert GL
    J Clin Microbiol; 2013 Jul; 51(7):2245-9. PubMed ID: 23658265
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection of markers predictive of macrolide and fluoroquinolone resistance in
    Day MJ; Cole MJ; Fifer H; Woodford N; Pitt R
    Sex Transm Infect; 2022 May; 98(3):215-218. PubMed ID: 34088790
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High levels of macrolide resistance-associated mutations in Mycoplasma genitalium warrant antibiotic susceptibility-guided treatment.
    Nijhuis RH; Severs TT; Van der Vegt DS; Van Zwet AA; Kusters JG
    J Antimicrob Chemother; 2015 Sep; 70(9):2515-8. PubMed ID: 25995292
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection of markers predictive of macrolide and fluoroquinolone resistance in
    Pitt R; Fifer H; Woodford N; Alexander S
    Sex Transm Infect; 2018 Feb; 94(1):9-13. PubMed ID: 28717051
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence of mutations associated with resistance to macrolides and fluoroquinolones in Mycoplasma genitalium: a systematic review and meta-analysis.
    Machalek DA; Tao Y; Shilling H; Jensen JS; Unemo M; Murray G; Chow EPF; Low N; Garland SM; Vodstrcil LA; Fairley CK; Hocking JS; Zhang L; Bradshaw CS
    Lancet Infect Dis; 2020 Nov; 20(11):1302-1314. PubMed ID: 32622378
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Surveillance of the prevalence of macrolide and/or fluoroquinolone resistance-associated mutations in Mycoplasma genitalium in Japan.
    Deguchi T; Ito S; Yasuda M; Sato Y; Uchida C; Sawamura M; Manda K; Takanashi M; Kiyota H
    J Infect Chemother; 2018 Nov; 24(11):861-867. PubMed ID: 30190106
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mutations in ParC and GyrA of moxifloxacin-resistant and susceptible Mycoplasma genitalium strains.
    Hamasuna R; Le PT; Kutsuna S; Furubayashi K; Matsumoto M; Ohmagari N; Fujimoto N; Matsumoto T; Jensen JS
    PLoS One; 2018; 13(6):e0198355. PubMed ID: 29883482
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Emergence of Mycoplasma genitalium strains showing mutations associated with macrolide and fluoroquinolone resistance in the region Dresden, Germany.
    Dumke R; Thürmer A; Jacobs E
    Diagn Microbiol Infect Dis; 2016 Oct; 86(2):221-3. PubMed ID: 27448452
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection of Macrolide and/or Fluoroquinolone Resistance Genes in
    Ljubin-Sternak S; Meštrović T; Marijan T; Anušić M; Šuto S; Vraneš J
    Genes (Basel); 2024 Apr; 15(4):. PubMed ID: 38674404
    [No Abstract]   [Full Text] [Related]  

  • 15. Macrolide and fluoroquinolone resistance-associated mutations in Mycoplasma genitalium in Johannesburg, South Africa, 2007-2014.
    Muller EE; Mahlangu MP; Lewis DA; Kularatne RS
    BMC Infect Dis; 2019 Feb; 19(1):148. PubMed ID: 30760230
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mycoplasma genitalium Macrolide and Fluoroquinolone Resistance Detection and Clinical Implications in a Selected Cohort in New Zealand.
    Anderson T; Coughlan E; Werno A
    J Clin Microbiol; 2017 Nov; 55(11):3242-3248. PubMed ID: 28878004
    [No Abstract]   [Full Text] [Related]  

  • 17. High prevalence of antibiotic-resistant Mycoplasma genitalium in nongonococcal urethritis: the need for routine testing and the inadequacy of current treatment options.
    Pond MJ; Nori AV; Witney AA; Lopeman RC; Butcher PD; Sadiq ST
    Clin Infect Dis; 2014 Mar; 58(5):631-7. PubMed ID: 24280088
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment efficacy, treatment failures and selection of macrolide resistance in patients with high load of Mycoplasma genitalium during treatment of male urethritis with josamycin.
    Guschin A; Ryzhikh P; Rumyantseva T; Gomberg M; Unemo M
    BMC Infect Dis; 2015 Feb; 15():40. PubMed ID: 25645440
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increasing Macrolide and Fluoroquinolone Resistance in Mycoplasma genitalium.
    Murray GL; Bradshaw CS; Bissessor M; Danielewski J; Garland SM; Jensen JS; Fairley CK; Tabrizi SN
    Emerg Infect Dis; 2017 May; 23(5):809-812. PubMed ID: 28418319
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mycoplasma genitalium Macrolide and Fluoroquinolone Resistance: Prevalence and Risk Factors Among a 2013-2014 Cohort of Patients in Barcelona, Spain.
    Barberá MJ; Fernández-Huerta M; Jensen JS; Caballero E; Andreu A
    Sex Transm Dis; 2017 Aug; 44(8):457-462. PubMed ID: 28703723
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.